Radiopharmaceutical Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of Radiopharmaceutical in global, including the following market information:
Global Radiopharmaceutical Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Radiopharmaceutical Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Radiopharmaceutical companies in 2020 (%)
The global Radiopharmaceutical market was valued at 6509.1 million in 2020 and is projected to reach US$ 8931.3 million by 2027, at a CAGR of 8.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceutical manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Radiopharmaceutical Market Segment Percentages, By Type, 2020 (%)
Global Radiopharmaceutical Market Segment Percentages, By Application, 2020 (%)
Global Radiopharmaceutical Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Radiopharmaceutical revenues share in global market, 2020 (%)
Key companies Radiopharmaceutical sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Radiopharmaceutical sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Radiopharmaceutical Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Radiopharmaceutical Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Radiopharmaceutical companies in 2020 (%)
The global Radiopharmaceutical market was valued at 6509.1 million in 2020 and is projected to reach US$ 8931.3 million by 2027, at a CAGR of 8.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Radiopharmaceutical manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Radiopharmaceutical Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Radiopharmaceutical Market Segment Percentages, By Type, 2020 (%)
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
Global Radiopharmaceutical Market Segment Percentages, By Application, 2020 (%)
- Oncology
- Cardiology
- Other
Global Radiopharmaceutical Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Radiopharmaceutical revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Radiopharmaceutical revenues share in global market, 2020 (%)
Key companies Radiopharmaceutical sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Radiopharmaceutical sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICAL OVERALL MARKET SIZE
2.1 Global Radiopharmaceutical Market Size: 2021 VS 2027
2.2 Global Radiopharmaceutical Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Radiopharmaceutical Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Radiopharmaceutical Players in Global Market
3.2 Top Global Radiopharmaceutical Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Revenue by Companies
3.4 Global Radiopharmaceutical Sales by Companies
3.5 Global Radiopharmaceutical Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceutical Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceutical Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Radiopharmaceutical Market Size Markets, 2021 & 2027
4.1.2 Actinium-225
4.1.3 Lutetium-177
4.1.4 Radium-223
4.1.5 Holmium-166
4.1.6 Other
4.2 By Type - Global Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Revenue, 2016-2021
4.2.2 By Type - Global Radiopharmaceutical Revenue, 2022-2027
4.2.3 By Type - Global Radiopharmaceutical Revenue Market Share, 2016-2027
4.3 By Type - Global Radiopharmaceutical Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceutical Sales, 2016-2021
4.3.2 By Type - Global Radiopharmaceutical Sales, 2022-2027
4.3.3 By Type - Global Radiopharmaceutical Sales Market Share, 2016-2027
4.4 By Type - Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Revenue, 2016-2021
5.2.2 By Application - Global Radiopharmaceutical Revenue, 2022-2027
5.2.3 By Application - Global Radiopharmaceutical Revenue Market Share, 2016-2027
5.3 By Application - Global Radiopharmaceutical Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceutical Sales, 2016-2021
5.3.2 By Application - Global Radiopharmaceutical Sales, 2022-2027
5.3.3 By Application - Global Radiopharmaceutical Sales Market Share, 2016-2027
5.4 By Application - Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Radiopharmaceutical Market Size, 2021 & 2027
6.2 By Region - Global Radiopharmaceutical Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Revenue, 2016-2021
6.2.2 By Region - Global Radiopharmaceutical Revenue, 2022-2027
6.2.3 By Region - Global Radiopharmaceutical Revenue Market Share, 2016-2027
6.3 By Region - Global Radiopharmaceutical Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceutical Sales, 2016-2021
6.3.2 By Region - Global Radiopharmaceutical Sales, 2022-2027
6.3.3 By Region - Global Radiopharmaceutical Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Radiopharmaceutical Revenue, 2016-2027
6.4.2 By Country - North America Radiopharmaceutical Sales, 2016-2027
6.4.3 US Radiopharmaceutical Market Size, 2016-2027
6.4.4 Canada Radiopharmaceutical Market Size, 2016-2027
6.4.5 Mexico Radiopharmaceutical Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceutical Revenue, 2016-2027
6.5.2 By Country - Europe Radiopharmaceutical Sales, 2016-2027
6.5.3 Germany Radiopharmaceutical Market Size, 2016-2027
6.5.4 France Radiopharmaceutical Market Size, 2016-2027
6.5.5 U.K. Radiopharmaceutical Market Size, 2016-2027
6.5.6 Italy Radiopharmaceutical Market Size, 2016-2027
6.5.7 Russia Radiopharmaceutical Market Size, 2016-2027
6.5.8 Nordic Countries Radiopharmaceutical Market Size, 2016-2027
6.5.9 Benelux Radiopharmaceutical Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceutical Revenue, 2016-2027
6.6.2 By Region - Asia Radiopharmaceutical Sales, 2016-2027
6.6.3 China Radiopharmaceutical Market Size, 2016-2027
6.6.4 Japan Radiopharmaceutical Market Size, 2016-2027
6.6.5 South Korea Radiopharmaceutical Market Size, 2016-2027
6.6.6 Southeast Asia Radiopharmaceutical Market Size, 2016-2027
6.6.7 India Radiopharmaceutical Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Radiopharmaceutical Revenue, 2016-2027
6.7.2 By Country - South America Radiopharmaceutical Sales, 2016-2027
6.7.3 Brazil Radiopharmaceutical Market Size, 2016-2027
6.7.4 Argentina Radiopharmaceutical Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceutical Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Radiopharmaceutical Sales, 2016-2027
6.8.3 Turkey Radiopharmaceutical Market Size, 2016-2027
6.8.4 Israel Radiopharmaceutical Market Size, 2016-2027
6.8.5 Saudi Arabia Radiopharmaceutical Market Size, 2016-2027
6.8.6 UAE Radiopharmaceutical Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporate Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Major Product Offerings
7.1.4 Bracco Imaging Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.1.5 Bracco Imaging Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Major Product Offerings
7.2.4 Bayer Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.2.5 Bayer Key News
7.3 Mallinckrodt
7.3.1 Mallinckrodt Corporate Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Major Product Offerings
7.3.4 Mallinckrodt Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.3.5 Mallinckrodt Key News
7.4 Nordion
7.4.1 Nordion Corporate Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Major Product Offerings
7.4.4 Nordion Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.4.5 Nordion Key News
7.5 Triad Isotopes
7.5.1 Triad Isotopes Corporate Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Major Product Offerings
7.5.4 Triad Isotopes Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.5.5 Triad Isotopes Key News
7.6 Lantheus
7.6.1 Lantheus Corporate Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Major Product Offerings
7.6.4 Lantheus Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.6.5 Lantheus Key News
7.7 IBA Group
7.7.1 IBA Group Corporate Summary
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Major Product Offerings
7.4.4 IBA Group Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.7.5 IBA Group Key News
7.8 GE Healthcare
7.8.1 GE Healthcare Corporate Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Major Product Offerings
7.8.4 GE Healthcare Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.8.5 GE Healthcare Key News
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Corporate Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Major Product Offerings
7.9.4 China Isotope & Radiation Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.9.5 China Isotope & Radiation Key News
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Corporate Summary
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Major Product Offerings
7.10.4 Jubilant Pharma Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.10.5 Jubilant Pharma Key News
7.11 Eli Lilly
7.11.1 Eli Lilly Corporate Summary
7.11.2 Eli Lilly Radiopharmaceutical Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Major Product Offerings
7.11.4 Eli Lilly Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.11.5 Eli Lilly Key News
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Corporate Summary
7.12.2 Advanced Accelerator Applications Radiopharmaceutical Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Major Product Offerings
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.12.5 Advanced Accelerator Applications Key News
7.13 SIEMENS
7.13.1 SIEMENS Corporate Summary
7.13.2 SIEMENS Radiopharmaceutical Business Overview
7.13.3 SIEMENS Radiopharmaceutical Major Product Offerings
7.13.4 SIEMENS Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.13.5 SIEMENS Key News
7.14 Dongcheng
7.14.1 Dongcheng Corporate Summary
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Major Product Offerings
7.14.4 Dongcheng Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.14.5 Dongcheng Key News
7.15 Navidea
7.15.1 Navidea Corporate Summary
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Major Product Offerings
7.15.4 Navidea Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.15.5 Navidea Key News
8 GLOBAL RADIOPHARMACEUTICAL PRODUCTION CAPACITY, ANALYSIS
8.1 Global Radiopharmaceutical Production Capacity, 2016-2027
8.2 Radiopharmaceutical Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceutical Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RADIOPHARMACEUTICAL SUPPLY CHAIN ANALYSIS
10.1 Radiopharmaceutical Industry Value Chain
10.2 Radiopharmaceutical Upstream Market
10.3 Radiopharmaceutical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceutical Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Radiopharmaceutical Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiopharmaceutical Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RADIOPHARMACEUTICAL OVERALL MARKET SIZE
2.1 Global Radiopharmaceutical Market Size: 2021 VS 2027
2.2 Global Radiopharmaceutical Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Radiopharmaceutical Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top Radiopharmaceutical Players in Global Market
3.2 Top Global Radiopharmaceutical Companies Ranked by Revenue
3.3 Global Radiopharmaceutical Revenue by Companies
3.4 Global Radiopharmaceutical Sales by Companies
3.5 Global Radiopharmaceutical Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Radiopharmaceutical Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Radiopharmaceutical Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiopharmaceutical Players in Global Market
3.8.1 List of Global Tier 1 Radiopharmaceutical Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Radiopharmaceutical Market Size Markets, 2021 & 2027
4.1.2 Actinium-225
4.1.3 Lutetium-177
4.1.4 Radium-223
4.1.5 Holmium-166
4.1.6 Other
4.2 By Type - Global Radiopharmaceutical Revenue & Forecasts
4.2.1 By Type - Global Radiopharmaceutical Revenue, 2016-2021
4.2.2 By Type - Global Radiopharmaceutical Revenue, 2022-2027
4.2.3 By Type - Global Radiopharmaceutical Revenue Market Share, 2016-2027
4.3 By Type - Global Radiopharmaceutical Sales & Forecasts
4.3.1 By Type - Global Radiopharmaceutical Sales, 2016-2021
4.3.2 By Type - Global Radiopharmaceutical Sales, 2022-2027
4.3.3 By Type - Global Radiopharmaceutical Sales Market Share, 2016-2027
4.4 By Type - Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Radiopharmaceutical Market Size, 2021 & 2027
5.1.2 Oncology
5.1.3 Cardiology
5.1.4 Other
5.2 By Application - Global Radiopharmaceutical Revenue & Forecasts
5.2.1 By Application - Global Radiopharmaceutical Revenue, 2016-2021
5.2.2 By Application - Global Radiopharmaceutical Revenue, 2022-2027
5.2.3 By Application - Global Radiopharmaceutical Revenue Market Share, 2016-2027
5.3 By Application - Global Radiopharmaceutical Sales & Forecasts
5.3.1 By Application - Global Radiopharmaceutical Sales, 2016-2021
5.3.2 By Application - Global Radiopharmaceutical Sales, 2022-2027
5.3.3 By Application - Global Radiopharmaceutical Sales Market Share, 2016-2027
5.4 By Application - Global Radiopharmaceutical Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global Radiopharmaceutical Market Size, 2021 & 2027
6.2 By Region - Global Radiopharmaceutical Revenue & Forecasts
6.2.1 By Region - Global Radiopharmaceutical Revenue, 2016-2021
6.2.2 By Region - Global Radiopharmaceutical Revenue, 2022-2027
6.2.3 By Region - Global Radiopharmaceutical Revenue Market Share, 2016-2027
6.3 By Region - Global Radiopharmaceutical Sales & Forecasts
6.3.1 By Region - Global Radiopharmaceutical Sales, 2016-2021
6.3.2 By Region - Global Radiopharmaceutical Sales, 2022-2027
6.3.3 By Region - Global Radiopharmaceutical Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Radiopharmaceutical Revenue, 2016-2027
6.4.2 By Country - North America Radiopharmaceutical Sales, 2016-2027
6.4.3 US Radiopharmaceutical Market Size, 2016-2027
6.4.4 Canada Radiopharmaceutical Market Size, 2016-2027
6.4.5 Mexico Radiopharmaceutical Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Radiopharmaceutical Revenue, 2016-2027
6.5.2 By Country - Europe Radiopharmaceutical Sales, 2016-2027
6.5.3 Germany Radiopharmaceutical Market Size, 2016-2027
6.5.4 France Radiopharmaceutical Market Size, 2016-2027
6.5.5 U.K. Radiopharmaceutical Market Size, 2016-2027
6.5.6 Italy Radiopharmaceutical Market Size, 2016-2027
6.5.7 Russia Radiopharmaceutical Market Size, 2016-2027
6.5.8 Nordic Countries Radiopharmaceutical Market Size, 2016-2027
6.5.9 Benelux Radiopharmaceutical Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Radiopharmaceutical Revenue, 2016-2027
6.6.2 By Region - Asia Radiopharmaceutical Sales, 2016-2027
6.6.3 China Radiopharmaceutical Market Size, 2016-2027
6.6.4 Japan Radiopharmaceutical Market Size, 2016-2027
6.6.5 South Korea Radiopharmaceutical Market Size, 2016-2027
6.6.6 Southeast Asia Radiopharmaceutical Market Size, 2016-2027
6.6.7 India Radiopharmaceutical Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Radiopharmaceutical Revenue, 2016-2027
6.7.2 By Country - South America Radiopharmaceutical Sales, 2016-2027
6.7.3 Brazil Radiopharmaceutical Market Size, 2016-2027
6.7.4 Argentina Radiopharmaceutical Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Radiopharmaceutical Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Radiopharmaceutical Sales, 2016-2027
6.8.3 Turkey Radiopharmaceutical Market Size, 2016-2027
6.8.4 Israel Radiopharmaceutical Market Size, 2016-2027
6.8.5 Saudi Arabia Radiopharmaceutical Market Size, 2016-2027
6.8.6 UAE Radiopharmaceutical Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporate Summary
7.1.2 Bracco Imaging Business Overview
7.1.3 Bracco Imaging Radiopharmaceutical Major Product Offerings
7.1.4 Bracco Imaging Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.1.5 Bracco Imaging Key News
7.2 Bayer
7.2.1 Bayer Corporate Summary
7.2.2 Bayer Business Overview
7.2.3 Bayer Radiopharmaceutical Major Product Offerings
7.2.4 Bayer Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.2.5 Bayer Key News
7.3 Mallinckrodt
7.3.1 Mallinckrodt Corporate Summary
7.3.2 Mallinckrodt Business Overview
7.3.3 Mallinckrodt Radiopharmaceutical Major Product Offerings
7.3.4 Mallinckrodt Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.3.5 Mallinckrodt Key News
7.4 Nordion
7.4.1 Nordion Corporate Summary
7.4.2 Nordion Business Overview
7.4.3 Nordion Radiopharmaceutical Major Product Offerings
7.4.4 Nordion Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.4.5 Nordion Key News
7.5 Triad Isotopes
7.5.1 Triad Isotopes Corporate Summary
7.5.2 Triad Isotopes Business Overview
7.5.3 Triad Isotopes Radiopharmaceutical Major Product Offerings
7.5.4 Triad Isotopes Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.5.5 Triad Isotopes Key News
7.6 Lantheus
7.6.1 Lantheus Corporate Summary
7.6.2 Lantheus Business Overview
7.6.3 Lantheus Radiopharmaceutical Major Product Offerings
7.6.4 Lantheus Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.6.5 Lantheus Key News
7.7 IBA Group
7.7.1 IBA Group Corporate Summary
7.7.2 IBA Group Business Overview
7.7.3 IBA Group Radiopharmaceutical Major Product Offerings
7.4.4 IBA Group Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.7.5 IBA Group Key News
7.8 GE Healthcare
7.8.1 GE Healthcare Corporate Summary
7.8.2 GE Healthcare Business Overview
7.8.3 GE Healthcare Radiopharmaceutical Major Product Offerings
7.8.4 GE Healthcare Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.8.5 GE Healthcare Key News
7.9 China Isotope & Radiation
7.9.1 China Isotope & Radiation Corporate Summary
7.9.2 China Isotope & Radiation Business Overview
7.9.3 China Isotope & Radiation Radiopharmaceutical Major Product Offerings
7.9.4 China Isotope & Radiation Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.9.5 China Isotope & Radiation Key News
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Corporate Summary
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Radiopharmaceutical Major Product Offerings
7.10.4 Jubilant Pharma Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.10.5 Jubilant Pharma Key News
7.11 Eli Lilly
7.11.1 Eli Lilly Corporate Summary
7.11.2 Eli Lilly Radiopharmaceutical Business Overview
7.11.3 Eli Lilly Radiopharmaceutical Major Product Offerings
7.11.4 Eli Lilly Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.11.5 Eli Lilly Key News
7.12 Advanced Accelerator Applications
7.12.1 Advanced Accelerator Applications Corporate Summary
7.12.2 Advanced Accelerator Applications Radiopharmaceutical Business Overview
7.12.3 Advanced Accelerator Applications Radiopharmaceutical Major Product Offerings
7.12.4 Advanced Accelerator Applications Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.12.5 Advanced Accelerator Applications Key News
7.13 SIEMENS
7.13.1 SIEMENS Corporate Summary
7.13.2 SIEMENS Radiopharmaceutical Business Overview
7.13.3 SIEMENS Radiopharmaceutical Major Product Offerings
7.13.4 SIEMENS Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.13.5 SIEMENS Key News
7.14 Dongcheng
7.14.1 Dongcheng Corporate Summary
7.14.2 Dongcheng Business Overview
7.14.3 Dongcheng Radiopharmaceutical Major Product Offerings
7.14.4 Dongcheng Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.14.5 Dongcheng Key News
7.15 Navidea
7.15.1 Navidea Corporate Summary
7.15.2 Navidea Business Overview
7.15.3 Navidea Radiopharmaceutical Major Product Offerings
7.15.4 Navidea Radiopharmaceutical Sales and Revenue in Global (2016-2021)
7.15.5 Navidea Key News
8 GLOBAL RADIOPHARMACEUTICAL PRODUCTION CAPACITY, ANALYSIS
8.1 Global Radiopharmaceutical Production Capacity, 2016-2027
8.2 Radiopharmaceutical Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiopharmaceutical Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RADIOPHARMACEUTICAL SUPPLY CHAIN ANALYSIS
10.1 Radiopharmaceutical Industry Value Chain
10.2 Radiopharmaceutical Upstream Market
10.3 Radiopharmaceutical Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiopharmaceutical Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Radiopharmaceutical in Global Market
Table 2. Top Radiopharmaceutical Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Radiopharmaceutical Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Radiopharmaceutical Revenue Share by Companies, 2016-2021
Table 5. Global Radiopharmaceutical Sales by Companies, (M Doses), 2016-2021
Table 6. Global Radiopharmaceutical Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceutical Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Radiopharmaceutical Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 15. By Type - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 16. By Application – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 20. By Application - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 21. By Region – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 25. By Region - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 26. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 29. By Country - North America Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 38. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 41. By Country - South America Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 46. Bracco Imaging Corporate Summary
Table 47. Bracco Imaging Radiopharmaceutical Product Offerings
Table 48. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. Bayer Corporate Summary
Table 50. Bayer Radiopharmaceutical Product Offerings
Table 51. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. Mallinckrodt Corporate Summary
Table 53. Mallinckrodt Radiopharmaceutical Product Offerings
Table 54. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. Nordion Corporate Summary
Table 56. Nordion Radiopharmaceutical Product Offerings
Table 57. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 58. Triad Isotopes Corporate Summary
Table 59. Triad Isotopes Radiopharmaceutical Product Offerings
Table 60. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 61. Lantheus Corporate Summary
Table 62. Lantheus Radiopharmaceutical Product Offerings
Table 63. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 64. IBA Group Corporate Summary
Table 65. IBA Group Radiopharmaceutical Product Offerings
Table 66. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 67. GE Healthcare Corporate Summary
Table 68. GE Healthcare Radiopharmaceutical Product Offerings
Table 69. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 70. China Isotope & Radiation Corporate Summary
Table 71. China Isotope & Radiation Radiopharmaceutical Product Offerings
Table 72. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 73. Jubilant Pharma Corporate Summary
Table 74. Jubilant Pharma Radiopharmaceutical Product Offerings
Table 75. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 76. Eli Lilly Corporate Summary
Table 77. Eli Lilly Radiopharmaceutical Product Offerings
Table 78. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 79. Advanced Accelerator Applications Corporate Summary
Table 80. Advanced Accelerator Applications Radiopharmaceutical Product Offerings
Table 81. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 82. SIEMENS Corporate Summary
Table 83. SIEMENS Radiopharmaceutical Product Offerings
Table 84. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 85. Dongcheng Corporate Summary
Table 86. Dongcheng Radiopharmaceutical Product Offerings
Table 87. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 88. Navidea Corporate Summary
Table 89. Navidea Radiopharmaceutical Product Offerings
Table 90. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 91. Radiopharmaceutical Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 92. Global Radiopharmaceutical Capacity Market Share of Key Manufacturers, 2019-2021
Table 93. Global Radiopharmaceutical Production by Region, 2016-2021 (M Doses)
Table 94. Global Radiopharmaceutical Production by Region, 2022-2027 (M Doses)
Table 95. Radiopharmaceutical Market Opportunities & Trends in Global Market
Table 96. Radiopharmaceutical Market Drivers in Global Market
Table 97. Radiopharmaceutical Market Restraints in Global Market
Table 98. Radiopharmaceutical Raw Materials
Table 99. Radiopharmaceutical Raw Materials Suppliers in Global Market
Table 100. Typical Radiopharmaceutical Downstream
Table 101. Radiopharmaceutical Downstream Clients in Global Market
Table 102. Radiopharmaceutical Distributors and Sales Agents in Global Market
Table 1. Key Players of Radiopharmaceutical in Global Market
Table 2. Top Radiopharmaceutical Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Radiopharmaceutical Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Radiopharmaceutical Revenue Share by Companies, 2016-2021
Table 5. Global Radiopharmaceutical Sales by Companies, (M Doses), 2016-2021
Table 6. Global Radiopharmaceutical Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Radiopharmaceutical Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Radiopharmaceutical Product Type
Table 9. List of Global Tier 1 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Radiopharmaceutical Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 15. By Type - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 16. By Application – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 20. By Application - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 21. By Region – Global Radiopharmaceutical Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Radiopharmaceutical Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Radiopharmaceutical Sales (M Doses), 2016-2021
Table 25. By Region - Global Radiopharmaceutical Sales (M Doses), 2022-2027
Table 26. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 29. By Country - North America Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 38. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 41. By Country - South America Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Radiopharmaceutical Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Radiopharmaceutical Sales, (M Doses), 2022-2027
Table 46. Bracco Imaging Corporate Summary
Table 47. Bracco Imaging Radiopharmaceutical Product Offerings
Table 48. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. Bayer Corporate Summary
Table 50. Bayer Radiopharmaceutical Product Offerings
Table 51. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. Mallinckrodt Corporate Summary
Table 53. Mallinckrodt Radiopharmaceutical Product Offerings
Table 54. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. Nordion Corporate Summary
Table 56. Nordion Radiopharmaceutical Product Offerings
Table 57. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 58. Triad Isotopes Corporate Summary
Table 59. Triad Isotopes Radiopharmaceutical Product Offerings
Table 60. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 61. Lantheus Corporate Summary
Table 62. Lantheus Radiopharmaceutical Product Offerings
Table 63. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 64. IBA Group Corporate Summary
Table 65. IBA Group Radiopharmaceutical Product Offerings
Table 66. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 67. GE Healthcare Corporate Summary
Table 68. GE Healthcare Radiopharmaceutical Product Offerings
Table 69. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 70. China Isotope & Radiation Corporate Summary
Table 71. China Isotope & Radiation Radiopharmaceutical Product Offerings
Table 72. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 73. Jubilant Pharma Corporate Summary
Table 74. Jubilant Pharma Radiopharmaceutical Product Offerings
Table 75. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 76. Eli Lilly Corporate Summary
Table 77. Eli Lilly Radiopharmaceutical Product Offerings
Table 78. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 79. Advanced Accelerator Applications Corporate Summary
Table 80. Advanced Accelerator Applications Radiopharmaceutical Product Offerings
Table 81. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 82. SIEMENS Corporate Summary
Table 83. SIEMENS Radiopharmaceutical Product Offerings
Table 84. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 85. Dongcheng Corporate Summary
Table 86. Dongcheng Radiopharmaceutical Product Offerings
Table 87. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 88. Navidea Corporate Summary
Table 89. Navidea Radiopharmaceutical Product Offerings
Table 90. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 91. Radiopharmaceutical Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 92. Global Radiopharmaceutical Capacity Market Share of Key Manufacturers, 2019-2021
Table 93. Global Radiopharmaceutical Production by Region, 2016-2021 (M Doses)
Table 94. Global Radiopharmaceutical Production by Region, 2022-2027 (M Doses)
Table 95. Radiopharmaceutical Market Opportunities & Trends in Global Market
Table 96. Radiopharmaceutical Market Drivers in Global Market
Table 97. Radiopharmaceutical Market Restraints in Global Market
Table 98. Radiopharmaceutical Raw Materials
Table 99. Radiopharmaceutical Raw Materials Suppliers in Global Market
Table 100. Typical Radiopharmaceutical Downstream
Table 101. Radiopharmaceutical Downstream Clients in Global Market
Table 102. Radiopharmaceutical Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Radiopharmaceutical Segment by Type
Figure 2. Radiopharmaceutical Segment by Application
Figure 3. Global Radiopharmaceutical Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Radiopharmaceutical Revenue, 2016-2027 (US$, Mn)
Figure 7. Radiopharmaceutical Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceutical Revenue in 2020
Figure 9. By Type - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 10. By Type - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 11. By Type - Global Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 12. By Application - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 13. By Application - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 14. By Application - Global Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 15. By Region - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 16. By Region - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 17. By Country - North America Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 18. By Country - North America Radiopharmaceutical Sales Market Share, 2016-2027
Figure 19. US Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Radiopharmaceutical Sales Market Share, 2016-2027
Figure 24. Germany Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 25. France Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Radiopharmaceutical Sales Market Share, 2016-2027
Figure 33. China Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 37. India Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 39. By Country - South America Radiopharmaceutical Sales Market Share, 2016-2027
Figure 40. Brazil Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Radiopharmaceutical Sales Market Share, 2016-2027
Figure 44. Turkey Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 48. Global Radiopharmaceutical Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Radiopharmaceutical by Region, 2020 VS 2027
Figure 50. Radiopharmaceutical Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Radiopharmaceutical Segment by Type
Figure 2. Radiopharmaceutical Segment by Application
Figure 3. Global Radiopharmaceutical Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Radiopharmaceutical Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Radiopharmaceutical Revenue, 2016-2027 (US$, Mn)
Figure 7. Radiopharmaceutical Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Radiopharmaceutical Revenue in 2020
Figure 9. By Type - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 10. By Type - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 11. By Type - Global Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 12. By Application - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 13. By Application - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 14. By Application - Global Radiopharmaceutical Price (USD/Dose), 2016-2027
Figure 15. By Region - Global Radiopharmaceutical Sales Market Share, 2016-2027
Figure 16. By Region - Global Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 17. By Country - North America Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 18. By Country - North America Radiopharmaceutical Sales Market Share, 2016-2027
Figure 19. US Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Radiopharmaceutical Sales Market Share, 2016-2027
Figure 24. Germany Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 25. France Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Radiopharmaceutical Sales Market Share, 2016-2027
Figure 33. China Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 37. India Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 39. By Country - South America Radiopharmaceutical Sales Market Share, 2016-2027
Figure 40. Brazil Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Radiopharmaceutical Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Radiopharmaceutical Sales Market Share, 2016-2027
Figure 44. Turkey Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Radiopharmaceutical Revenue, (US$, Mn), 2016-2027
Figure 48. Global Radiopharmaceutical Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Radiopharmaceutical by Region, 2020 VS 2027
Figure 50. Radiopharmaceutical Industry Value Chain
Figure 51. Marketing Channels
